IL117809A - Medical patch for rate-controlled transdermal administration of risperidone - Google Patents

Medical patch for rate-controlled transdermal administration of risperidone

Info

Publication number
IL117809A
IL117809A IL11780996A IL11780996A IL117809A IL 117809 A IL117809 A IL 117809A IL 11780996 A IL11780996 A IL 11780996A IL 11780996 A IL11780996 A IL 11780996A IL 117809 A IL117809 A IL 117809A
Authority
IL
Israel
Prior art keywords
risperidone
rate
transdermal administration
medical patch
controlled transdermal
Prior art date
Application number
IL11780996A
Other languages
English (en)
Other versions
IL117809A0 (en
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL117809A0 publication Critical patent/IL117809A0/xx
Publication of IL117809A publication Critical patent/IL117809A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL11780996A 1995-04-06 1996-04-03 Medical patch for rate-controlled transdermal administration of risperidone IL117809A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95200867 1995-04-06

Publications (2)

Publication Number Publication Date
IL117809A0 IL117809A0 (en) 1996-08-04
IL117809A true IL117809A (en) 2000-10-31

Family

ID=8220172

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11780996A IL117809A (en) 1995-04-06 1996-04-03 Medical patch for rate-controlled transdermal administration of risperidone

Country Status (16)

Country Link
EP (1) EP0879051B9 (es)
JP (1) JPH11503138A (es)
KR (1) KR100437672B1 (es)
AR (1) AR003413A1 (es)
AT (1) ATE242631T1 (es)
CA (1) CA2214420A1 (es)
CY (1) CY2388B1 (es)
DE (1) DE69628672T2 (es)
DK (1) DK0879051T3 (es)
ES (1) ES2201176T3 (es)
HR (1) HRP960154A2 (es)
IL (1) IL117809A (es)
PT (1) PT879051E (es)
TW (1) TW592729B (es)
WO (1) WO1996031201A1 (es)
ZA (1) ZA962752B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10042412B4 (de) * 2000-08-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Abgabe von Venlafaxin, und seine Verwendung
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
EP1661560B1 (en) * 2004-11-22 2008-11-05 Hisamitsu Pharmaceutical Co., Inc. Transdermal patch comprising a melting point lowering agent
WO2006093139A1 (ja) * 2005-02-28 2006-09-08 Hisamitsu Pharmaceutical Co., Inc. 経皮吸収製剤
WO2007035942A2 (en) * 2005-09-23 2007-03-29 Alza Corporation Transdermal risperidone delivery system
RU2445959C2 (ru) 2006-06-09 2012-03-27 ДАЙНИППОН СУМИТОМО ФАРМА Ко., ЛТД. Новый лейкопластырный препарат
DE102007006244B4 (de) 2007-02-08 2012-03-15 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System zur Verabreichung wasserlöslicher Wirkstoffe
US8927537B2 (en) * 2007-12-21 2015-01-06 Nuvo Research Inc. Patches, formulations, and associated methods for transdermal delivery of alprazolam and other drugs
JPWO2010098261A1 (ja) * 2009-02-24 2012-08-30 久光製薬株式会社 リスペリドン含有経皮吸収型製剤及びこれを用いた貼付剤
CN117815210A (zh) * 2023-01-04 2024-04-05 新领医药技术(深圳)有限公司 利培酮透皮施用系统及其制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
US4710191A (en) * 1985-12-16 1987-12-01 Jonergin, Inc. Therapeutic device for the administration of medicaments
US4938759A (en) * 1986-09-02 1990-07-03 Alza Corporation Transdermal delivery device having a rate controlling adhesive
US5788983A (en) * 1989-04-03 1998-08-04 Rutgers, The State University Of New Jersey Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
WO1991002527A1 (en) * 1989-08-21 1991-03-07 Beth Israel Hospital Association Method and composition for the treatment of cutaneous, ocular, and mucosal hypersensitivity, inflammation, and hyperproliferative conditions using topical preparations of serotonin antagonists

Also Published As

Publication number Publication date
AR003413A1 (es) 1998-08-05
DK0879051T3 (da) 2003-09-29
EP0879051B1 (en) 2003-06-11
AU5149296A (en) 1996-10-23
DE69628672T2 (de) 2004-04-29
JPH11503138A (ja) 1999-03-23
ATE242631T1 (de) 2003-06-15
HK1015681A1 (en) 1999-10-22
WO1996031201A1 (en) 1996-10-10
TW592729B (en) 2004-06-21
CY2388B1 (en) 2004-09-10
AU696789B2 (en) 1998-09-17
EP0879051A1 (en) 1998-11-25
EP0879051B9 (en) 2004-03-03
PT879051E (pt) 2003-10-31
ES2201176T3 (es) 2004-03-16
IL117809A0 (en) 1996-08-04
CA2214420A1 (en) 1996-10-10
ZA962752B (en) 1997-10-06
HRP960154A2 (en) 1997-08-31
DE69628672D1 (de) 2003-07-17
KR100437672B1 (ko) 2004-09-10

Similar Documents

Publication Publication Date Title
AU7070596A (en) Transdermal administration of olanzapine
IL117728A0 (en) Pharmaceutical compositions for transdermal administration
AU5397996A (en) Iontophoretic transdermal system for the administration of at least two substances
AU4334497A (en) Iontophoretic drug delivery system including method for activating same for attachment to patient
AU7236596A (en) Transdermal administration of ropinirole and analogs thereof
AU5263496A (en) Targeted catheter drug administration
AU6094996A (en) Diphosphonate derivatives of therapeutic agents
AU1041599A (en) Therapeutic uses of triazolo-pyridazine derivatives
ATE210429T1 (de) Therapie mittels gleichförmiger arzneistoffverabreichung
AU2939897A (en) Administration of histamine for therapeutic purposes
IL117809A (en) Medical patch for rate-controlled transdermal administration of risperidone
GB2256588B8 (en) Preparation for transdermal administration of procaterol
HUP0001263A3 (en) Methods of therapeutic administration of anti-cd4ol compounds
AU6934691A (en) Transdermal administration of zwitterionic drugs
GB9700737D0 (en) Administration of drugs
AU7291996A (en) Transdermal therapeutic system (tts) for the administration of drugs for treatment of drug dependency or drug addiction
AU8869398A (en) Medical apparatus for relief of pain
HUP9801130A3 (en) Transdermal therapeutic system for administering testosterone
AU2617288A (en) Pharmaceutical formulations for transdermal administration
AU4457496A (en) Use of melatonin for treating patients suffering from drug addiction
AU6821196A (en) Transdermal administration of vorozole
PL325242A1 (en) Method of obtaining solid drug administration forms for very low dosage drugs
AU1727397A (en) Application of pyrrolidine derivatives to the preparation of medicaments for the treatment of drug abuse
AU2462097A (en) The use of a substance p antagonist for the manufacture of medicament for the treatment of ocular pain
IL116615A (en) Transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazole and of its salts

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired